Tau, a central driver of cytoskeletal collapse in AD, undergoes site-specific hyperphosphorylation, leading to its dissociation from microtubules, the disruption of cytoskeletal dynamics, and the impaired axonal transport of mitochondria and vesicles [24,25,35,36,37,38]. The gene discussed is MAPT; the disease is Alzheimer disease.